EUVIMEDEUVIMED entdecken
Crossref

26-A-12564-ACC EFFECTIVENESS OF LDL-C LOWERING WITH ALIROCUMAB AND INCLISIRAN IN A CLINICAL PRACTICE SETTING

Maciej Banach, amelia carro, Dominik Schulte, Sigrun Halvorsen, Irfan Khan, Hagai Tavori, zhouyang lou, Robert Hegele, Miguel Cainzos Achirica, Margrét Leósdóttir

JACC · 2026-04 · 87 (13) · A271

DOI: 10.1016/j.jacc.2026.02.673 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Maciej Banach und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Banach, M., carro, A., Schulte, D., Halvorsen, S., Khan, I., Tavori, H., lou, Z., Hegele, R., Achirica, M. C., & Leósdóttir, M. (2026). 26-A-12564-ACC EFFECTIVENESS OF LDL-C LOWERING WITH ALIROCUMAB AND INCLISIRAN IN A CLINICAL PRACTICE SETTING. JACC, 87(13), A271. https://doi.org/10.1016/j.jacc.2026.02.673

Vancouver

Banach M, carro A, Schulte D, Halvorsen S, Khan I, Tavori H, et al. 26-A-12564-ACC EFFECTIVENESS OF LDL-C LOWERING WITH ALIROCUMAB AND INCLISIRAN IN A CLINICAL PRACTICE SETTING. JACC. 2026;87(13):A271. doi:10.1016/j.jacc.2026.02.673

BibTeX
@article{Banach2026,
  author = {Banach, Maciej and carro, amelia and Schulte, Dominik and Halvorsen, Sigrun and Khan, Irfan and Tavori, Hagai and lou, zhouyang and Hegele, Robert and Achirica, Miguel Cainzos and Leósdóttir, Margrét},
  title = {26-A-12564-ACC EFFECTIVENESS OF LDL-C LOWERING WITH ALIROCUMAB AND INCLISIRAN IN A CLINICAL PRACTICE SETTING},
  journal = {JACC},
  year = {2026},
  volume = {87},
  number = {13},
  pages = {A271},
  doi = {10.1016/j.jacc.2026.02.673}
}
Kostenlos starten →